Amarantus Bioscience Holdings Inc (AMBS)

[Calm68]

Lympro has more than two revenue options.

Expediter - False dichotomy. You suggest that Lympro can only be too expensive for insurance to pick up or too cheap to make money. What's the price point you're thinking? $1500 is too expensive and $1499.99 is too cheap?

Might it not be possible that say $2000 is too expensive and $200 is too cheap but that somewhere in between might be a price point that works as a win/win?